CTLT vs NAGE
CTLT (CTLT) versus Niagen Bioscience, Inc. (NAGE) — a side-by-side from cached financials, not a winner call.
CTLT (CTLT) common stock.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
CTLT does not have a complete income-statement cache yet.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Not investment advice. Open the CTLT and NAGE stock pages for the full models.
Not investment advice.